Thursday, August 13, 2026

HYBE Chairman Bang Si Hyuk Supports Debut of New Girl Group I’LL-IT

Belift Lab, a subsidiary of HYBE (352820), has officially announced the debut date for their new girl group, I'LL-IT.

Why September Sees the Most Food Poisoning Cases: Tips to Stay Safe

As autumn arrives, food poisoning cases rise. Ensure proper food storage, thorough cooking, and maintain hygiene to prevent illness.

North Korea Stages Response to U.S.-ROK Drills, Avoids Reporting on Own Missile Launch

North Korea criticizes U.S.-South Korea joint exercise Freedom Shield while remaining silent on its own missile launches.

Classys Showcases Expanding Aesthetics Portfolio at ASLMS 2026 as U.S. Push Accelerates

HealthClassys Showcases Expanding Aesthetics Portfolio at ASLMS 2026 as U.S. Push Accelerates
A view of the Classys booth at ASLMS 2026 held in Savannah, Georgia, U.S. / Provided by Classys
A view of the Classys booth at ASLMS 2026 held in Savannah, Georgia, U.S. / Provided by Classys

Global medical aesthetics company Classys recently participated in the 45th Annual Conference of the American Society for Laser Medicine and Surgery (ASLMS) in Savannah, Georgia, the company announced on Monday.

Classys has been rapidly expanding its global market presence, anchored by its high-frequency device Everesse (known as Volnewmer in the U.S.). The company has further bolstered its robust two-pronged portfolio with the addition of Quadessy (QUADESSY), a next-generation microneedling RF device launched in the U.S. in March 2026.

Classys aims to shake up the existing competitive landscape in the U.S. market by offering a comprehensive lineup. This includes the soon-to-be-released laser Reepot (REEPOT) slated for launch this year, and the High-Intensity Focused Ultrasound (HIFU) device Ultraformer MPT (marketed internationally as Shurink Universe) set for a 2027 debut. Together, these offerings will cover the full spectrum of aesthetic treatments, from skin lifting to pigmentation correction.

With its participation in ASLMS 2026, Classys intends to accelerate its expansion in the U.S. market.

The company’s strategy goes beyond single-product focus. Instead, Classys aims to maximize clinical utility through an integrated portfolio based on multiple platforms. This approach allows for versatile treatment combinations and tailored patient solutions, setting Classys apart in the market.

A Classys spokesperson emphasized that for them, the U.S. market isn’t just about gaining a foothold; it’s a key strategic arena where we must establish leadership. It’s poised to rapidly expand the market influence through the technologically advanced and clinically proven portfolio, setting new benchmarks in the global energy-based device market.

Classys, founded in 2007, is a global leader in medical aesthetics, currently supplying state-of-the-art aesthetic medical devices to over 80 countries worldwide.

The company has cultivated a diverse energy-based device (EBD) portfolio, featuring: the globally top-ranked Shurink Universe, a focused ultrasound (HIFU) lifting device; Volnewmer, a cutting-edge monopolar radiofrequency (MRF) volumizing solution; Quadessy, an advanced microneedle radiofrequency (MNRF) system; the Reepot laser device; and Shurink Home Lift to Glow, a home beauty device leveraging medical-grade technology.

Check Out Our Content

Check Out Other Tags:

Most Popular Articles